pubmed.ncbi.nlm.nih.gov

In Vitro Susceptibility of Thai Pythium insidiosum Isolates to Antibacterial Agents - PubMed

️Wed Jan 01 2020

In Vitro Susceptibility of Thai Pythium insidiosum Isolates to Antibacterial Agents

Navaporn Worasilchai et al. Antimicrob Agents Chemother. 2020.

Abstract

Human pythiosis is a life-threatening human disease caused by Pythium insidiosum In Thailand, vascular pythiosis is the most common form and carries a mortality rate of 10 to 40%, despite aggressive treatment with radical surgery, antifungal agents, and immunotherapy. Itraconazole and terbinafine have been the mainstay of treatment, until recently, based on case report data showing potential synergistic effects against Brazilian P. insidiosum isolates. However, the synergistic effects of itraconazole and terbinafine against Thai P. insidiosum isolates were not observed. This study tested the in vitro susceptibilities of 27 Thai human P. insidiosum isolates (clade II, n = 17; clade IV, n = 10), 12 Thai environmental P. insidiosum isolates (clade II, n = 4; clade IV, n = 8), and 11 non-Thai animal P. insidiosum isolates (clade I, n = 9; clade II, n = 2) to antibiotics in eight antibacterial classes to evaluate alternative effective treatments. Tetracycline and macrolide antibiotics demonstrated in vitro activity against Thai P. insidiosum isolates, with doxycycline MICs (1 to 16 μg/ml), minocycline MICs (1 to 4 μg/ml), tigecycline MICs (1 to 4 μg/ml), azithromycin MICs (1 to 16 μg/ml), and clarithromycin MICs (0.125 to 8 μg/ml) being the lowest, on average. Synergistic effects of tetracyclines and macrolides were also observed.

Keywords: Pythium insidiosum; antibacterial agents; susceptibility profile.

PubMed Disclaimer

Cited by

A Review: Antimicrobial Therapy for Human Pythiosis.
Medhasi S, Chindamporn A, Worasilchai N. Medhasi S, et al. Antibiotics (Basel). 2022 Mar 26;11(4):450. doi: 10.3390/antibiotics11040450. Antibiotics (Basel). 2022. PMID: 35453202 Free PMC article. Review.
Selection of an Appropriate In Vitro Susceptibility Test for Assessing Anti-Pythium insidiosum Activity of Potassium Iodide, Triamcinolone Acetonide, Dimethyl Sulfoxide, and Ethanol.
Yolanda H, Lohnoo T, Rujirawat T, Yingyong W, Kumsang Y, Sae-Chew P, Payattikul P, Krajaejun T. Yolanda H, et al. J Fungi (Basel). 2022 Oct 24;8(11):1116. doi: 10.3390/jof8111116. J Fungi (Basel). 2022. PMID: 36354883 Free PMC article.
Clinical Characteristics, Histopathology, and Treatment Outcomes of Pythium Keratitis: A Retrospective Cohort Study.
Puangsricharern V, Chotikkakamthorn P, Tulvatana W, Kittipibul T, Chantaren P, Reinprayoon U, Kasetsuwan N, Satitpitakul V, Worasilchai N, Chindamporn A. Puangsricharern V, et al. Clin Ophthalmol. 2021 Apr 23;15:1691-1701. doi: 10.2147/OPTH.S303721. eCollection 2021. Clin Ophthalmol. 2021. PMID: 33935486 Free PMC article.
Clinical Outcomes of Radical Surgery and Antimicrobial Agents in Vascular Pythiosis: A Multicenter Prospective Study.
Torvorapanit P, Chuleerarux N, Plongla R, Worasilchai N, Manothummetha K, Thongkam A, Langsiri N, Diewsurin J, Kongsakpaisan P, Bansong R, Susaengrat N, Wattanasoontornsakul W, Chindamporn A, Permpalung N. Torvorapanit P, et al. J Fungi (Basel). 2021 Feb 4;7(2):114. doi: 10.3390/jof7020114. J Fungi (Basel). 2021. PMID: 33557064 Free PMC article.
History and Perspective of Immunotherapy for Pythiosis.
Yolanda H, Krajaejun T. Yolanda H, et al. Vaccines (Basel). 2021 Sep 26;9(10):1080. doi: 10.3390/vaccines9101080. Vaccines (Basel). 2021. PMID: 34696188 Free PMC article. Review.

References

1. Presser JW, Goss EM. 2015. Environmental sampling reveals that Pythium insidiosum is ubiquitous and genetically diverse in North Central Florida. Med Mycol 53:674–683. doi:10.1093/mmy/myv054. - DOI - PubMed
1. Vilela R, Montalva C, Luz C, Humber RA, Mendoza L. 2018. Pythium insidiosum isolated from infected mosquito larvae in central Brazil. Acta Trop 185:344–348. doi:10.1016/j.actatropica.2018.06.014. - DOI - PubMed
1. Permpalung N, Worasilchai N, Manothummetha K, Torvorapanit P, Ratanawongphaibul K, Chuleerarux N, Plongla R, Chindamporn A. 2019. Clinical outcomes in ocular pythiosis patients treated with a combination therapy protocol in Thailand: a prospective study. Med Mycol 57:923–928. doi:10.1093/mmy/myz013. - DOI - PubMed
1. Permpalung N, Worasilchai N, Plongla R, Upala S, Sanguankeo A, Paitoonpong L, Mendoza L, Chindamporn A. 2015. Treatment outcomes of surgery, antifungal therapy and immunotherapy in ocular and vascular human pythiosis: a retrospective study of 18 patients. J Antimicrob Chemother 70:1885–1892. doi:10.1093/jac/dkv008. - DOI - PubMed
1. Gaastra W, Lipman LJ, De Cock AW, Exel TK, Pegge RB, Scheurwater J, Vilela R, Mendoza L. 2010. Pythium insidiosum: an overview. Vet Microbiol 146:1–16. doi:10.1016/j.vetmic.2010.07.019. - DOI - PubMed

In Vitro Susceptibility of Thai Pythium insidiosum Isolates to Antibacterial Agents - PubMed